These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 17204044)

  • 1. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):71-7. PubMed ID: 17045473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the impact of genetic susceptibility testing for BRCA1/2 or HNPCC on family relationships.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Riedijk SR; van Dooren S; Tibben A
    Psychooncology; 2007 Apr; 16(4):320-8. PubMed ID: 16909428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Psychooncology; 2007 Dec; 16(12):1121-9. PubMed ID: 17328098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coping with genetic testing for breast cancer susceptibility.
    Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
    Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
    Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
    Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    Patenaude AF; Dorval M; DiGianni LS; Schneider KA; Chittenden A; Garber JE
    J Clin Oncol; 2006 Feb; 24(4):700-6. PubMed ID: 16446344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
    McCann S; MacAuley D; Barnett Y; Bunting B; Bradley A; Jeffers L; Morrison PJ
    Psychooncology; 2009 Nov; 18(11):1208-15. PubMed ID: 19177338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
    Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
    Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
    van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
    J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing.
    Smith KR; West JA; Croyle RT; Botkin JR
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):385-92. PubMed ID: 10207644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: reactions and behavior after the disclosure of a positive test result.
    Bonadona V; Saltel P; Desseigne F; Mignotte H; Saurin JC; Wang Q; Sinilnikova O; Giraud S; Freyer G; Plauchu H; Puisieux A; Lasset C
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):97-104. PubMed ID: 11815406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How families communicate about HNPCC genetic testing: findings from a qualitative study.
    Peterson SK; Watts BG; Koehly LM; Vernon SW; Baile WF; Kohlmann WK; Gritz ER
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):78-86. PubMed ID: 12704641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.
    Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB
    Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
    van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
    J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
    Gritz ER; Peterson SK; Vernon SW; Marani SK; Baile WF; Watts BG; Amos CI; Frazier ML; Lynch PM
    J Clin Oncol; 2005 Mar; 23(9):1902-10. PubMed ID: 15774782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
    Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
    Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A literature review of the psychological impact of genetic testing on breast cancer patients.
    Schlich-Bakker KJ; ten Kroode HF; Ausems MG
    Patient Educ Couns; 2006 Jul; 62(1):13-20. PubMed ID: 16242293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.